West Pharmaceutical Services Debt/Equity Ratio 2010-2024 | WST

West Pharmaceutical Services debt/equity ratio for the quarter ending September 30, 2024 was 0.07.

  • West Pharmaceutical Services average debt/equity ratio for 2023 was 0.06, a 33.33% increase from 2022.
  • West Pharmaceutical Services average debt/equity ratio for 2022 was 0.09, a 18.18% decline from 2021.
  • West Pharmaceutical Services average debt/equity ratio for 2021 was 0.11, a 31.25% decline from 2020.

Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

West Pharmaceutical Services Debt/Equity Ratio 2010-2024 | WST

  • West Pharmaceutical Services average debt/equity ratio for 2023 was 0.06, a 33.33% increase from 2022.
  • West Pharmaceutical Services average debt/equity ratio for 2022 was 0.09, a 18.18% decline from 2021.
  • West Pharmaceutical Services average debt/equity ratio for 2021 was 0.11, a 31.25% decline from 2020.

Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.